These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28459045)

  • 21. Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project.
    Ritchie K; Ropacki M; Albala B; Harrison J; Kaye J; Kramer J; Randolph C; Ritchie CW
    Alzheimers Dement; 2017 Feb; 13(2):186-195. PubMed ID: 27702619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An initiative using informatics to facilitate clinical research planning and recruitment in the VA health care system.
    Velarde KE; Romesser JM; Johnson MR; Clegg DO; Efimova O; Oostema SJ; Scehnet JS; DuVall SL; Huang GD
    Contemp Clin Trials Commun; 2018 Sep; 11():107-112. PubMed ID: 30035242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarker and Clinical Trial Design Support for Disease-Modifying Therapies: Report of a Survey of the EU/US: Alzheimer's Disease Task Force.
    Cummings J; Fox N; Vellas B; Aisen P; Shan G
    J Prev Alzheimers Dis; 2018; 5(2):103-109. PubMed ID: 29616703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repurposed agents in the Alzheimer's disease drug development pipeline.
    Bauzon J; Lee G; Cummings J
    Alzheimers Res Ther; 2020 Aug; 12(1):98. PubMed ID: 32807237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Trial Educator program - a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial.
    Kendall B; Städeli R; Schegg B; Olbrich M; Chen E; Harmelin-Kadouri R; Aurup P; Schwab T; Hildemann SK
    Clin Trials; 2012 Jun; 9(3):358-66. PubMed ID: 22426648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recruitment across two decades of NIH-funded Alzheimer's disease clinical trials.
    Ritchie M; Gillen DL; Grill JD
    Alzheimers Res Ther; 2023 Feb; 15(1):28. PubMed ID: 36732846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium.
    Frisoni GB; Henneman WJ; Weiner MW; Scheltens P; Vellas B; Reynish E; Hudecova J; Hampel H; Burger K; Blennow K; Waldemar G; Johannsen P; Wahlund LO; Zito G; Rossini PM; Winblad B; Barkhof F;
    Alzheimers Dement; 2008 Jul; 4(4):255-64. PubMed ID: 18631976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early termination of pivotal trials in Alzheimer's disease-Preserving optimal value for participants and science.
    Gietl AF; Frisoni GB
    Alzheimers Dement; 2022 Oct; 18(10):1980-1987. PubMed ID: 35220681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years.
    Walter S; Langford OG; Clanton TB; Jimenez-Maggiora GA; Raman R; Rafii MS; Shaffer EJ; Sperling RA; Cummings JL; Aisen PS
    J Prev Alzheimers Dis; 2020; 7(4):234-241. PubMed ID: 32920625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aß Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan.
    Siemers E; Hitchcock J; Sundell K; Dean R; Jerecic J; Cline E; Iverson K; Moore J; Edgar C; Manber R; Fuin N; Poppe T; Barton R
    J Prev Alzheimers Dis; 2023; 10(1):19-24. PubMed ID: 36641606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology.
    Jimenez-Maggiora GA; Bruschi S; Raman R; Langford O; Donohue M; Rafii MS; Sperling RA; Cummings JL; Aisen PS
    J Prev Alzheimers Dis; 2020; 7(4):226-233. PubMed ID: 32920624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A Report of an International Research Collaboration Network.
    Pavlik VN; Burnham SC; Kass JS; Helmer C; Palmqvist S; Vassilaki M; Dartigues JF; Hansson O; Masters CL; Pérès K; Petersen RC; Stomrud E; Butler L; Coloma PM; Teitsma XM; Doody R; Sano M;
    J Alzheimers Dis; 2022; 85(1):31-45. PubMed ID: 34776434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team.
    Arnerić SP; Batrla-Utermann R; Beckett L; Bittner T; Blennow K; Carter L; Dean R; Engelborghs S; Genius J; Gordon MF; Hitchcock J; Kaplow J; Luthman J; Meibach R; Raunig D; Romero K; Samtani MN; Savage M; Shaw L; Stephenson D; Umek RM; Vanderstichele H; Willis B; Yule S
    J Alzheimers Dis; 2017; 55(1):19-35. PubMed ID: 27662307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mismatched double-stranded RNA: polyI:polyC12U.
    Adis Editorial
    Drugs R D; 2004; 5(5):297-304. PubMed ID: 15357629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recruitment and Screening Methods in Alzheimer's Disease Research: The FIT-AD Trial.
    Greimel S; Wyman JF; Zhang L; Yu F
    J Gerontol A Biol Sci Med Sci; 2022 Mar; 77(3):547-553. PubMed ID: 33780529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The China tuberculosis clinical trials consortium network: a model for international TB clinical trials capacity building.
    Liu YH; Chen S; Gao JT; Zhang Y; Booher K; Ding XF; Shu W; Du J; Bao J; Hafner R; Hamilton CD; Li L
    Infect Dis Poverty; 2020 May; 9(1):52. PubMed ID: 32414419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.